Ethic Inc. Buys 1,552 Shares of Henry Schein, Inc. (NASDAQ:HSIC)

Ethic Inc. lifted its holdings in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 13.1% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 13,423 shares of the company’s stock after purchasing an additional 1,552 shares during the period. Ethic Inc.’s holdings in Henry Schein were worth $929,000 as of its most recent filing with the SEC.

Other hedge funds also recently modified their holdings of the company. Venturi Wealth Management LLC lifted its holdings in Henry Schein by 3,347.1% in the fourth quarter. Venturi Wealth Management LLC now owns 586 shares of the company’s stock valued at $41,000 after buying an additional 569 shares during the period. Quent Capital LLC increased its stake in Henry Schein by 91.2% in the fourth quarter. Quent Capital LLC now owns 677 shares of the company’s stock valued at $47,000 after purchasing an additional 323 shares in the last quarter. Smartleaf Asset Management LLC increased its stake in Henry Schein by 23.2% in the fourth quarter. Smartleaf Asset Management LLC now owns 759 shares of the company’s stock valued at $52,000 after purchasing an additional 143 shares in the last quarter. City State Bank bought a new stake in shares of Henry Schein during the fourth quarter worth about $55,000. Finally, Allworth Financial LP increased its position in shares of Henry Schein by 180.7% during the fourth quarter. Allworth Financial LP now owns 946 shares of the company’s stock worth $71,000 after acquiring an additional 609 shares in the last quarter. Institutional investors and hedge funds own 96.62% of the company’s stock.

Insiders Place Their Bets

In other news, Director Philip A. Laskawy sold 2,604 shares of the firm’s stock in a transaction dated Wednesday, March 19th. The shares were sold at an average price of $71.04, for a total value of $184,988.16. Following the completion of the sale, the director now directly owns 24,805 shares of the company’s stock, valued at approximately $1,762,147.20. This trade represents a 9.50% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, CEO Bradford C. Connett sold 4,036 shares of the firm’s stock in a transaction dated Wednesday, March 19th. The stock was sold at an average price of $71.15, for a total transaction of $287,161.40. Following the completion of the sale, the chief executive officer now directly owns 62,688 shares of the company’s stock, valued at approximately $4,460,251.20. This represents a 6.05% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 1.08% of the company’s stock.

Wall Street Analyst Weigh In

Several equities research analysts have recently commented on HSIC shares. StockNews.com downgraded shares of Henry Schein from a “buy” rating to a “hold” rating in a research report on Thursday, April 17th. UBS Group dropped their target price on shares of Henry Schein from $83.00 to $80.00 and set a “neutral” rating on the stock in a research note on Wednesday, February 26th. Piper Sandler dropped their target price on shares of Henry Schein from $83.00 to $77.00 and set an “overweight” rating on the stock in a research note on Wednesday, April 30th. Jefferies Financial Group upped their price target on shares of Henry Schein from $77.00 to $80.00 and gave the company a “hold” rating in a research note on Thursday, January 23rd. Finally, Wells Fargo & Company decreased their target price on shares of Henry Schein from $80.00 to $75.00 and set an “equal weight” rating on the stock in a report on Tuesday, May 6th. Six research analysts have rated the stock with a hold rating, five have given a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat, Henry Schein currently has a consensus rating of “Moderate Buy” and a consensus price target of $79.30.

Henry Schein Price Performance

Shares of NASDAQ:HSIC opened at $70.54 on Wednesday. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.42 and a quick ratio of 0.82. Henry Schein, Inc. has a one year low of $60.56 and a one year high of $82.49. The company’s fifty day moving average price is $67.52 and its 200-day moving average price is $71.45. The firm has a market capitalization of $8.59 billion, a price-to-earnings ratio of 29.03, a PEG ratio of 2.13 and a beta of 0.87.

Henry Schein (NASDAQ:HSIC) last released its earnings results on Monday, May 5th. The company reported $1.15 EPS for the quarter, beating the consensus estimate of $1.11 by $0.04. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The company had revenue of $3.17 billion for the quarter, compared to analyst estimates of $3.24 billion. During the same quarter last year, the firm earned $1.10 EPS. The firm’s quarterly revenue was down .1% compared to the same quarter last year. On average, equities research analysts anticipate that Henry Schein, Inc. will post 4.74 earnings per share for the current fiscal year.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.